| Literature DB >> 23866602 |
Abstract
The paper considers the problem of lipid-lowering therapy for chronic kidney disease, by using different groups of drugs, the expediency, efficiency, and safety of the therapy at different disease stages, including end-stage renal failure, and replacement treatments.Entities:
Mesh：
Substances：
Year: 2013 PMID： 23866602
Source DB: PubMed Journal: Ter Arkh ISSN： 0040-3660 Impact factor: 0.467